A marked tissue-specific increase in erythrocyte adenosine deaminase activity is associated with an autosomal dominantly inherited hemolytic anemia.
METABOLISM OF GUANINE ARABINOSIDE AND CYTOSINE
Mitchell, University of Michlgan Medical Center, Ann Arbor, Mi. USA. Guanine arabinoside (araG) and cytosine arabinoside (araC) are nucleoside analogs which elicit cytotoxicity twough their corresponding 5'-triphosphatq metabolites.
Although less potent than araC, araG is of interest as an antileukemic agent due to its selective toxicity to cultured T compared to B lymphoblasts.
In order to determine whether araC would exhibit a similar selectivity of action in vivo, we have examined the metabolism of this drug in mononuclear Cells from patients with leukemia.
Peripheral We have asked whether GTP depletion is indeed causal of HL-60 cell maturation induced by the I W dehydrogenase inhibitor mycophenolic acid (HA) and have compared the effects of W A on cellular metabolism with those of other differentiating agents. Cells grown in the presence of 2 pM W A were 85 f 6% differentiated on day 4 of culture. GTP pools were reduced to <20X of control values by 1 hr and remained low over the 4 day incubation period.
Repletion of guanine nucleotide pools within 24 hr of initiation of the cuture by exogenous guanosine in the presence of MPA prevented differentiation in wild type but not in HPRT-deficient HL-60 cells. There was no depletion of GTP associated with other differentiating agents and no reversal of differentiation with guanosine. W A treatment did not result in significant alterationa in intracellular CAMP, but did decrease cGMP to 50% of control levels at 24 hrs. There wece no changes in 32~-labelled protein patterns on autoradiographa of two dimensional protein gels after W A exposure. We conclude that depletion of guanine nucleotides is causally related to the HL-60 differentiation induced by I W dehydrogenase inhibitors but not by other inducers of differentiation of these cells. HPRT-deficient ED-virus transformed human lymphoblasts show decreased levels of ATP and GTP compared with control lymphoblasts. This decrease was not consistent.
REDUCED PURINE NUCLEOTTDE CONTENT AND POLY(ADP-RIBOSE) SYNTHETASE ACTIVITY IN HPRT-DEPTCJENT HUMAN LYMPIIO
The ATP content of the HPRT-deficient cells decreased to a significantly lower level than in control cells under unfavourable nutritional conditions, but not with frequent changes of medium. There was also a significant decrease in ADPribosylation in these cells.
The cells showed a significant positive correlation between ATP content and poly(ADP-ribose) synthetase activity and an inverse correlation between NAD content and poly(ADP-ribose) synthetase activity, as NAD is the substrate for this enzyme.
ADP-ribosylation is essential in many cellular processes including DNA repair and cell differentiation. So a decrease in ADP-ribosy1at:ion of nuclear protein may lead to decreased DNA repair. This may be a factor in explaining the long term deterioration of brain and testicular function in the LeschNyhan Syndrome.
MOLECULAR ASPECT OF MYOGENIC HYPERURICEMIA: CLONING

93
OF HUMAN MUSCLE PHOSPHOFRUCTOKINASE cDNA A partial HMPFK cDNA clone was isolated. The clone was primer-extended and two other overlapping clones to cover the full-length were isolated.
Complete primary structure of the enzyme was determined through the sequence analysis. HMPFK was 85,050 Da in size with 779 amino acid residues. Internal homology between N-and Chalves of the peptide was observed as in rabbit muscle PFK. Sequence homologies between rabbit and human muscle PFK were 96% in amino acids and 89X in nucleotides.
Cloning of HMPFK cDNA will help analyzing the pathological regulatory mechanism of muscle glycolysis responsible for the development of myogenic hyperuricemia at the molecular level.
CHANNELING OF IMP INTO GUANYLATE SYNTHESIS IN THE GROWTH PROGRAM OF HEPATOMA 3924A CELLS
94 Yutaka Natsumeda, Tadashi Ikcgami, Yasukazu Yamada, Yasufnmi Yamaji and Geor~e Weber Indiana University School of Medicine, Laboratory for Experimental Oncology, Indianapolis, Indiana, U.S.A. Thc purpose was to elucidate the relationship of IMP utilization for de novo guanylate and adenylate synthesis during the display of the proliferative program of hepatoma 392411 cells.
Purine compounds in the cells were labeled with [14~lformate or ~-[ 3 -~~~] s e r i n e in a serine-free assay medium, hydrolyzed to purine bases, separated and counted. Under these assay conditions labeling of adenine or guanine was proportionate with incubation time and with number of cells. During the transition of hepatoma cells from plateau phase into logarithmic proliferation the concentration of PRPP increased 14-fold, followed by an 8-fold rise in purine de novo synthesis. In plateau phase cells predominantly adcnylates were produced.
After replating the resting cells there was a sharp increase in the relative labeling of guanine with a concurrent marked decrease in that of adenine in the late lag phase. The subsequent decline of the relative labeling of guanine was accompanied with the restoration in that of adenine with the increase in the cell density. The striking redirection in the distribution of label from IMP utilization to the preferential synthesis of guanylates during the expression of the biochemical proliferative program of cancer cells underlines the potential significance of this pathway as a target of chemotherapy. (Supported by Outstanding Investigator Grant CA-42510 to G.W.)
